Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia

Monica Hazra, Hiroyuki Uchida, Beth Sproule, Gary Remington, Takefumi Suzuki, David C. Mamo

研究成果: Article査読

15 被引用数 (Scopus)


The objective was to examine effects of active interventions on physician's prescribing of antipsychotic polypharmacy. Prescriptions for patients with schizophrenia at the Centre for Addiction and Mental Health, Canada were collected in 2006 (n = 648) and 2008 (n = 778). During the intervening period, a pharmacist monitored prescriptions with antipsychotic polypharmacy and contacted corresponding prescribers to provide education on risks of polypharmacy. Moreover, educational sessions on polypharmacy were presented to inpatient and outpatient teams. A three-fold decrease in the prevalence of antipsychotic polypharmacy was observed between 2006 (18.3%) and 2008 (6.6%). Thus, active monitoring of prescriptions with educational interventions could reduce antipsychotic polypharmacy.

ジャーナルPsychiatry and Clinical Neurosciences
出版ステータスPublished - 2011 12

ASJC Scopus subject areas

  • Neuroscience(all)
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health

フィンガープリント 「Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。